Latest News

Date Title Topic
08 Mar 2016 Launch of EMA’s Priority Medicines Scheme Bioethics, legal and economic issues
08 Mar 2016 ESMO Open Press Release: High White Blood Cell Ratio Linked to Recurrence Risk in Early Stage Breast Cancer Breast cancer
18 Apr 2016 Optimising the Assessment and Therapy of Oesophago-Gastric Junction Adenocarcinomas
Webcasts
04 Mar 2016 ESMO is Proud That Charité Connects the Patient Guides to the Clinic’s Website
03 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
02 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Trifluridine/Tipiracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
01 Mar 2016 ESMO mourns the loss of Dr. Holbrook Kohrt
01 Mar 2016 EMA Recommends Extending Indications for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
International Study: Peer Review
29 Feb 2016 EMA Recommends Extending Indications for Afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Feb 2016 EMA Recommends Extending the Use of Nivolumab Genitourinary cancers - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
25 Feb 2016 US FDA Seeks Support for the National Cancer Moonshot Initiative Bioethics, legal and economic issues
24 Feb 2016 US NCI to Overhaul NCI-60 Tumour Cell Lines Translational research
23 Feb 2016 Palliative Care Fellowships Open for Application